An Insight into Puzzling Hypervirulent Klebsiella pneumoniae

Hypervirulent Klebsiella pneumoniae (hvKp) is a pathotype that differs sharply from the classical strain that most clinicians know from hospital-acquired infections. While classical strain typically affects debilitated, hospitalized patients and is often multidrug-resistant, hvKp causes community-acquired infections in otherwise healthy, younger adults. Now, hvKp is reported worldwide and growing concern is the convergence of hypervirulence with carbapenem resistance, creating strains that are both difficult to treat and capable of severe invasive disease.

The laboratory can reliably identify K. pneumoniae to species level, report antimicrobial susceptibility results, and flag a hypermucoviscous phenotype using the string test. But labelling an isolate as hvKp from routine testing is challenging. Susceptibility results also say nothing about virulence, so a fully susceptible isolate can still be hvKp, and the report should be worded cautiously.

Hypervirulent K. pneumoniae is a reminder that a pathogen’s name tells only part of the story: two isolates of the same species can behave very differently in the patient. Clinicians should maintain a high index of suspicion in a previously healthy person presents with liver abscess or infection at multiple sites, and should look for metastatic foci early, since prompt drainage and appropriate antibiotics improve outcomes. 

Laboratories should communicate clearly with the clinical team rather than rely on the report alone. Early conversation between bedside and bench is often what turns a puzzling infection into a well-managed one.

References

1. Russo TA, Lebreton F, McGann PT. A Step Forward in Hypervirulent Klebsiella pneumoniae Diagnostics. Emerg Infect Dis. 2025;31(1):1-3.

2. Russo TA, Olson R, Fang CT, et al. Identification of Biomarkers for Differentiation of Hypervirulent Klebsiella pneumoniae from Classical K. pneumoniae. J Clin Microbiol. 2018;56(9):e00776-18.

3. Russo TA, Alvarado CL, Davies CJ, et al. Differentiation of hypervirulent and classical Klebsiella pneumoniae with acquired drug resistance. mBio. 2024;15(2): e0286723.

4. Lee CR, Lee JH, Park KS, et al. Antimicrobial Resistance of Hypervirulent Klebsiella pneumoniae: Epidemiology, Hypervirulence-Associated Determinants, and Resistance Mechanisms. Front Cell Infect Microbiol.2017;7:483.

5. Gu D, Dong N, Zheng Z, et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis. 2018;18(1):37-46.

6. Russo TA, Marr CM. Hypervirulent Klebsiella pneumoniae. Clin Microbiol Rev. 2019;32(3): e00001-19.

7. Choby JE, Howard-Anderson J, Weiss DS. Hypervirulent Klebsiella pneumoniae: clinical and molecular perspectives. J Intern Med. 2020;287(3):283-300.

8. Wyres KL, Lam MMC, Holt KE. Population genomics of Klebsiella pneumoniae. Nat Rev Microbiol. 2020;18(6):344-359.

9. Shon AS, Bajwa RPS, Russo TA. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence. 2013;4(2):107-118.